Crossmark

Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study

Crossref DOI link: https://doi.org/10.1007/s40744-022-00524-y

Published Online: 2023-01-18

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bell, Christopher F. http://orcid.org/0000-0001-6413-2537
Chung, Jake

Rubin, Bernard
Funding

Funding for this research was provided by:

GSK
License Information

Text and Data Mining valid from 2023-01-18

Version of Record valid from 2023-01-18
More Information

Article History

Received: 16 September 2022

Accepted: 13 December 2022

First Online: 18 January 2023

Change Date: 23 November 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40744-023-00614-5

Updates are available Correction dated 2023-11-23

Click to view Correction: https://doi.org/10.1007/s40744-023-00614-5